Cafepharma Today

October 24 2024 - Weight-loss drugs didn't curb health costs within two years
Weight-loss drugs didn't curb health costs within two years
GSK answers Pfizer's RSV approval with data targeting matching nod in younger adults
Why pharma megamergers may become a relic of the past
Lundbeck planning for four novel drugs in phase 3 in 2026
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Daiichi Sankyo Completes Purchase of 63.9% of Ranbaxy
Bloomberg
Friday, November 7, 2008 - 9:47am
tags:
Big Pharma’s Loss May Be Little Pharma’s Gain
Pharmalot
Thursday, November 6, 2008 - 9:52am
tags:
Burrill: Biotech faces "a long down-turn"
Fierce Biotech
Thursday, November 6, 2008 - 9:52am
tags:
A Byetta Beating
Motley Fool
Thursday, November 6, 2008 - 9:51am
tags:
Vermont docs received more secret payments
Fierce Pharma
Thursday, November 6, 2008 - 9:49am
tags:
SciClone's Phase III hepatitis trial fails endpoint
Trading Markets
Thursday, November 6, 2008 - 9:46am
tags:
King Pharmaceuticals swings to third-quarter profit
Marketwatch
Thursday, November 6, 2008 - 9:28am
tags:
CV Therapeutics says FDA approved Ranexa as first-line angina treatment, expanding uses
Yahoo/AP
Thursday, November 6, 2008 - 9:26am
tags:
NeuroSearch's Gamble May Not Pay off After Acomplia Failure
Bloomberg
Thursday, November 6, 2008 - 9:25am
tags:
AstraZeneca Pill May Gain $3 Billion, If Test Works
Bloomberg
Thursday, November 6, 2008 - 9:23am
tags:
A.P. Pharma cuts 18 people, posts loss
Bizjournals.com
Thursday, November 6, 2008 - 9:22am
tags:
Glaxo Trades U.S. For Asia
Forbes
Thursday, November 6, 2008 - 8:44am
tags:
Glaxo to drop Philadelphia as U.S. headquarters
Bizjournals.com
Thursday, November 6, 2008 - 8:43am
tags:
October FDA news in review
Fierce Pharma
Thursday, November 6, 2008 - 8:07am
tags:
Teva net up 21%; forex effects are in focus
Marketwatch
Thursday, November 6, 2008 - 7:56am
tags:
Celera, Abbott Laboratories enter genetic technology deal to aid in treatment responses
Yahoo/AP
Thursday, November 6, 2008 - 7:55am
tags:
Drug stocks slide day after U.S. presidential election
Marketwatch
Thursday, November 6, 2008 - 7:53am
tags:
Pfizer Halts Obesity Drug on Risk of U.S. Rejection
Bloomberg
Thursday, November 6, 2008 - 7:51am
tags:
Sanofi Ends All Human Trials of Acomplia Obesity Drug
Bloomberg
Thursday, November 6, 2008 - 7:49am
tags:
Durect Headed in Right Direction
Yahoo/Zacks.com
Wednesday, November 5, 2008 - 8:48am
tags:

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

A Pfight at Pfizer
In the Pipeline
Clinical Trial Volunteers, And Others
In the Pipeline
The 340B Program Reached $66 Billion in 2023—Up 23% vs. 2022: Analyzing the Numbers and HRSA’s Curious Actions
Drug Channels
HCN in Acetonitrile, You Say?
In the Pipeline
Informa Connect’s Trade and Channel Strategies
Drug Channels
AI Does Not Make It Easy
In the Pipeline
The Promise of a Direct-to-Patient Model—Breaking Down What’s Really Needed for Better Patient Access
Drug Channels
Accelerated Approval: What Is It Accomplishing?
In the Pipeline
Cleaning up "Scientific Reports": Can It Be Done?
In the Pipeline

Latest Jobs

Account Manager-Orlando, FL-Ophthalmics
Maitland, Florida, 32794
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Alafaya, Florida
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Union Park, Florida
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Bunker Hill Village, Texas
Sun Pharmaceutical Industries, Inc.
Account Manager-Phoenix, AZ-Oncology
Paradise Valley, Arizona, 85253
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Pasadena, Texas, 77505
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Cloverleaf, Texas
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Gotha, Florida, 34734
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Longwood, Florida, 32791
Sun Pharmaceutical Industries, Inc.
Territory Manager - Medical Dermatology, Richmond VA
Richmond
Sun Pharmaceutical Industries, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information